These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
72 related items for PubMed ID: 17055066
21. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. Ponomarev ED, Shriver LP, Maresz K, Dittel BN. J Neurosci Res; 2005 Aug 01; 81(3):374-89. PubMed ID: 15959904 [Abstract] [Full Text] [Related]
22. Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Glabinski AR, Tani M, Strieter RM, Tuohy VK, Ransohoff RM. Am J Pathol; 1997 Feb 01; 150(2):617-30. PubMed ID: 9033275 [Abstract] [Full Text] [Related]
23. Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cells. Helmersson S, Sundstedt A, Deronic A, Leanderson T, Ivars F. Am J Pathol; 2013 May 01; 182(5):1671-80. PubMed ID: 23506849 [Abstract] [Full Text] [Related]
25. Protective DNA vaccination against experimental autoimmune encephalomyelitis is associated with induction of IFNbeta. Wefer J, Harris RA, Lobell A. J Neuroimmunol; 2004 Apr 01; 149(1-2):66-76. PubMed ID: 15020066 [Abstract] [Full Text] [Related]
26. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis. Cheng W, Zhao Q, Xi Y, Li C, Xu Y, Wang L, Niu X, Wang Z, Chen G. Mol Immunol; 2015 Mar 01; 64(1):152-62. PubMed ID: 25433436 [Abstract] [Full Text] [Related]
27. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, Warren KG, Andrade-Gordon P, Hollenberg MD, Power C. J Exp Med; 2006 Feb 20; 203(2):425-35. PubMed ID: 16476770 [Abstract] [Full Text] [Related]
28. Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis. Genoud S, Maricic I, Kumar V, Gage FH. J Neuroimmunol; 2005 Nov 20; 168(1-2):40-5. PubMed ID: 16120466 [Abstract] [Full Text] [Related]
29. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells. Strengell M, Lehtonen A, Matikainen S, Julkunen I. J Leukoc Biol; 2006 Jun 20; 79(6):1279-85. PubMed ID: 16551679 [Abstract] [Full Text] [Related]
30. Synergistic induction of IL-10 by hypertonic saline solution and lipopolysaccharides in murine peritoneal macrophages. Oreopoulos GD, Bradwell S, Lu Z, Fan J, Khadaroo R, Marshall JC, Li YH, Rotstein OD. Surgery; 2001 Aug 20; 130(2):157-65. PubMed ID: 11490344 [Abstract] [Full Text] [Related]
31. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor. Santambrogio L, Hochwald GM, Saxena B, Leu CH, Martz JE, Carlino JA, Ruddle NH, Palladino MA, Gold LI, Thorbecke GJ. J Immunol; 1993 Jul 15; 151(2):1116-27. PubMed ID: 8335893 [Abstract] [Full Text] [Related]
32. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis. Blaževski J, Petković F, Momčilović M, Jevtic B, Miljković D, Mostarica Stojković M. Immunobiology; 2013 Sep 15; 218(9):1192-9. PubMed ID: 23664544 [Abstract] [Full Text] [Related]
33. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation. Hesske L, Vincenzetti C, Heikenwalder M, Prinz M, Reith W, Fontana A, Suter T. Brain; 2010 Jun 15; 133(Pt 6):1637-54. PubMed ID: 20424288 [Abstract] [Full Text] [Related]
34. A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration. Rolls A, Cahalon L, Bakalash S, Avidan H, Lider O, Schwartz M. FASEB J; 2006 Mar 15; 20(3):547-9. PubMed ID: 16396993 [Abstract] [Full Text] [Related]
35. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes. Prêle CM, Keith-Magee AL, Yerkovich ST, Murcha M, Hart PH. Immunology; 2006 Sep 15; 119(1):8-17. PubMed ID: 16925527 [Abstract] [Full Text] [Related]
36. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis. Krakowski ML, Owens T. Eur J Immunol; 1997 Nov 15; 27(11):2840-7. PubMed ID: 9394808 [Abstract] [Full Text] [Related]
37. Deficient p75 low-affinity neurotrophin receptor expression does alter the composition of cellular infiltrate in experimental autoimmune encephalomyelitis in C57BL/6 mice. Küst B, Mantingh-Otter I, Boddeke E, Copray S. J Neuroimmunol; 2006 May 15; 174(1-2):92-100. PubMed ID: 16519950 [Abstract] [Full Text] [Related]
38. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. Wang Y, Mei Y, Feng D, Xu L. J Neurosci Res; 2008 Aug 15; 86(11):2441-9. PubMed ID: 18438925 [Abstract] [Full Text] [Related]